APR 14, 2018 06:40 AM PDT

A Vaccine for When Cancer Forms from Human Retroviruses

WRITTEN BY: Kara Marker

A vaccine to prevent leukemia and other diseases of the immune system caused by a specific viral infection is now a very real idea. A new study from Kyoto University ultimately led to the identification of a cancerous protein that could serve as a target for new vaccines.

Human cells with acute myelocytic leukemia (AML). Credit: National Cancer Institute

Diseases of the immune system like leukemia and other types of cancer often develop because of an infection by the retrovirus HTLV-4 (human T cell leukemia virus type 1). A retrovirus is a type of virus that uses RNA as its genetic material instead of DNA. After the virus infects a cell, like HTLV-1 does during leukemia, it uses an enzyme called transcriptase to convert its RNA into DNA. This conversion allows the virus to integrate into the DNA of the host cell and take over the cell’s machinery.

HTLV-1 was the first human retrovirus to be discovered, a “cousin” of HIV (human immunodeficiency virus). Like HIV, HTLV-1 transmission is linked with sexual contact, breastfeeding, and blood transfusions. HTLV-1 infects CD4+ T cells, an infection that can lead to leukemia and other diseases of the immune system. Uniquely, the virus thrives by remaining at very low levels in the body, essentially hiding from the immune system. Its genetic material is rarely detected in the plasma of infected individuals, study leader Jun-ichirou Yasunaga says.

HTLV-1 also encodes two oncogenic genes, called Tax and HBZ. Oncogenic genes are those that have the potential to cause cancer. Tax plays two roles - oncogenesis and viral replication - making it a powerful tool for HTLV-1.

Researchers studied infected leukemic cells to see how HTLV-1 and Tax worked to cause disease. They found that less than three percent of these cells express Tax at one time. Tax expression is transient, lasting less than 24 hours per cell. Researchers observed that it takes five months for 90 percent of the infected cells to have their turn to express Tax.

This fleeting mode of expression of Tax helps the virus hide from the immune system. It also helps to prevent apoptosis, a process of programmed cell death that is used by cells to self destruct when they’re infected to prevent other cells nearby from becoming infected too.

"There were clear differences in the gene expression between Tax-expressing and Tax-non-expressing cells,” Yasunaga explained. “In the latter there were two populations, those with medium, and those with low levels of anti-apoptotic factors. This shows that Tax caused different degrees of sensitivity to apoptosis.”

But when researchers manually suppressed Tax expression, nearly all HTLV-1-infected cells disappeared within one month.

"Transient Tax expression is a unique way through which enhances the survival and proliferation of infected cells, so it makes it a good vaccine target,” Yasunaga said. “Understanding its expression mechanism could be a key to new therapies.”

The present study was published in the journal Proceedings of the National Academy of Science.

Sources: AIDSinfo, Clinical Microbiology Reviews, Kyoto University

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
AUG 04, 2018
Immunology
AUG 04, 2018
Infant's Innate Immune Response
An infant's innate immune response develops from fetus to birth, but it may not be as "immature" as previously thought....
AUG 04, 2018
Microbiology
AUG 04, 2018
The Viral Link to Irritable Bowel Disease
We now know of the importance of the microbiome, but most of the research focus has been on bacteria....
AUG 08, 2018
Immunology
AUG 08, 2018
Doxorubicin Causes Heart Toxicity by Immune System Disruption
Chemotherapy drug Doxorubicin disrupts metabolism that controls immune responses in the heart leading to heart toxicity....
AUG 20, 2018
Immunology
AUG 20, 2018
Photosensitivity Linked to Immune Cell Dysfunction
The Langerhans cells of the immune system activate cytokines essential for skin protection when exposed to UV that is functional in photosensitive individuals....
AUG 29, 2018
Immunology
AUG 29, 2018
Artificial Intelligence Predicts Response to Immunotherapy
Artificial intelligence can process CT scan images to determine biological and clinical information that can predict immunotherapy efficacy thanks to machine learning....
NOV 12, 2018
Health & Medicine
NOV 12, 2018
Researchers find that obesity has a paradoxical effect on Cancer
Cancer therapy works differently in different people. Understanding what effects the individual body's response to treatment will be crucial for the development...
Loading Comments...